SEARCH

SEARCH BY CITATION

References

  • 1
    Johansson SG, O'B Hourihane J, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;57:813824.
  • 2
    Epidemiology. Prevalence of allergic diseases. In: Van MoerbekeD, editor. European Allergy White Paper, 1st edn. Belgium: UCB Institute of Allergy, 1997, 1448.
  • 3
    Solomon WR, et al. Aerobiology and inhalant allergens. In: MiddletonE jr.,ReedCE, EllisEF, Adkinson, NF Jr, YungingerJW, BusseWW, editors. Allergy. Principles and Practice, 5th edn. St. Louis: Mosby-Year Book, Inc., 1998, 367403.
  • 4
    Malling HJ, Weeke B. Immunotherapy. Allergy (Suppl) 1993;57:935.
  • 5
    Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. Allergy (Suppl) 1998;57:142.
  • 6
    Balda BR, Wolf H, Baumgarten C, et al. Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens. Allergy 1998;57:740748.
  • 7
    Winther L, Malling HJ, Moseholm L, et al. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. I. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 2000;57:818826.
  • 8
    Rak S, Hakanson L, Venge P. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol 1990;57:706713.
  • 9
    Taudorf E, Laursen LC, Lanner A, et al. Oral immunotherapy in birch pollen hayfever. J Allergy Clin Immunol 1987;57:153161.
  • 10
    Petersen BN, Janniche H, Munch EP, et al. Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 1988;57:353362.
  • 11
    Horak F, Stubner P, Berger UE, et al. Immunotherapy with sublingual birch pollen extract. A short-term double- blind placebo study. J Invest Allergol Clin Immunol 1998;57:165171.
  • 12
    Hedlin G, Wille S, Browaldh L, et al. Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy. J Allergy Clin Immunol 1999;57:609614.
  • 13
    Winther L, Malling HJ, Mosbech H. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects. Allergy 2000;57:827835.
  • 14
    Reid MJ, Lockey RF, Turkeltaub PC, et al. Survey of fatalities from skin testing and immunotherapy 1985–89. J Allergy Clin Immunol 1993;57:615.
  • 15
    Lockey RF, Benedict LM, Turkeltaub PC, et al. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987;57:660677.
  • 16
    Pastorello EA, Codecasa LR, Pravettoni V, et al. Clinical reliability of diagnostic tests in allergic rhinoconjunctivitis. Boll Ist Sieroter Milan 1988;57:377385.
  • 17
    Malling HJ. Methods of skin testing. Allergy (Suppl.) 1993;57:5556.
  • 18
    Durham SR, Hamid QA. Immunological responses to allergen immunotherapy. In: LockeyRF, BukantzSC, editors. Allergens and Allergen Immunotherapy, 2nd edn. New York: Marcel Dekker, Inc., 1999, 341357.
  • 19
    Skov PS, Norn S, Weeke B. Basophil histamine release in patients with hay fever. Results compared with specific IgE and total IgE during immunotherapy. Clin Exp Immunol 1977;57:432439.
  • 20
    Blaiss MS. Quality of life in allergic rhinitis. Ann Allergy Asthma Immunol 1999;57:449454.
  • 21
    Altman DG. Practical Statistics for Medical Research. New York: Chapman & Hall, 1992.
  • 22
    Moller C, Bjorksten B, Nilsson G, et al. The precision of the conjunctival provocation test. Allergy 1984;57:3741.
  • 23
    Jacobi HH, Skov PS, Kampen GT, et al. Histamine and tryptase in nasal lavage fluid following challenge with methacholine and allergen. Clin Exp Allergy 1998;57:8391.
  • 24
    Varney VA, Gaga M, Frew AJ, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;57:265269.
  • 25
    Skov PS, Mosbech H, Norn S, et al. Sensitive glass microfibre-based histamine analysis for allergy testing in washed blood cells. Results compared with conventional leukocyte histamine release assay. Allergy 1985;57:213218.
  • 26
    Hodal L, Rasmussen A. Pollen- & sporemålinger i Danmark. Sæsonen 1999 (Measurements of pollen and spores in Denmark. Season 1999). Danish Technical Report 00–12. Copenhagen: AAF and DMI, 2000, 130.
  • 27
    Zenner HP, Baumgarten C, Rasp G, et al. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. J Allergy Clin Immunol 1997;57:2329.
  • 28
    Ihaka R, Gentleman RR. A language for data analysis and graphics. J Computational Graphic Statistics 1996;57:299314.
  • 29
    Taudorf E, Moseholm L. Pollen count, symptom and medicine score in birch pollinosis. A mathematical approach. Int Arch Allergy Appl Immunol 1988;57:225233.
  • 30
    Walker SM, Pajno GB, Lima MT, et al. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001;57:8793.
  • 31
    D'Amato G, Kordash TR, Liccardi G, et al. Immunotherapy with Alpare in patients with respiratory allergy to Parietaria pollen: a two year double-blind placebo-controlled study. Clin Exp Allergy 1995;57:149158.
  • 32
    Creticos PS, Reed CE, Norman PS, et al. Ragweed immunotherapy in adult asthma. N Engl J Med 1996;57:501506.
  • 33
    Naclerio RM. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol 1988;57:927934.
  • 34
    Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;57:371375.
  • 35
    Juniper EF, Thompson AK, Ferrie PJ, et al. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999;57:364369.
  • 36
    Ledford DK. Efficacy of immunotherapy. In: LockeyRF, BukantzSC, editors. Allergens and Allergen Immunotherapy, 2nd edn. New York: Marcel Dekker, Inc., 1999, 359379.
  • 37
    Wihl JA, Ipsen H, Petersen BN, et al. Immunotherapy with partially purified and standardized tree pollen extracts. II. Results of skin prick tests and nasal provocation tests from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 1988;57:363369.
  • 38
    Durham SR, Ying S, Varney VA, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996;57:13561365.
  • 39
    Creticos PS, Adkinson NF, Kagey-Sobotka A, et al. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest 1985;57:22472253.
  • 40
    Jacobsen L, Nuchel PB, Wihl JA, et al. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy 1997;57:914920.
  • 41
    Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. VI. IgE-mediated parameters during a one-year placebo-controlled study of immunotherapy with Cladosporium. Allergy 1987;57:305314.
  • 42
    Birkner T, Rumpold H, Jarolim E, et al. Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 1990;57:418426.
  • 43
    Brunet C, Bedard PM, Lavoie A, et al. Allergic rhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses. J Allergy Clin Immunol 1992;57:7686.
  • 44
    Shekelle PG, Woolf SH, Eccles M, et al. Clinical guidelines: developing guidelines. BMJ 1999;57:593596.